American Journal of Analytical Chemistry

Volume 5, Issue 5 (April 2014)

ISSN Print: 2156-8251   ISSN Online: 2156-8278

Google-based Impact Factor: 1.71  Citations  h5-index & Ranking

Stress Degradation Studies on Lisinopril Dihydrate Using Modified Reverse Phase High Performance Liquid Chromatography

HTML  Download Download as PDF (Size: 682KB)  PP. 316-322  
DOI: 10.4236/ajac.2014.55039    6,564 Downloads   8,892 Views  Citations
Author(s)

ABSTRACT

A simple, precise, accurate and sensitive reverse phase high performance liquid chromatographic method for simultaneous estimation of lisinopril dihydrate and its degradation products occuring under different ICH prescribed stress conditions has been modified. Drug was resolved on a C18 column, utilizing modified mobile phase of tetra butyl ammonium hydroxide solution and acetonitrile. Ultra violet detection was carried out at 210 nm. The method was modified with respect to linearity, precision, accuracy, selectivity, specificity and ruggedness. The results obtained revealed that lisinopril dihydrate was an active product slightly changed under stress conditions.

Share and Cite:

Adam, E. (2014) Stress Degradation Studies on Lisinopril Dihydrate Using Modified Reverse Phase High Performance Liquid Chromatography. American Journal of Analytical Chemistry, 5, 316-322. doi: 10.4236/ajac.2014.55039.

Cited by

[1] Spectrophotometric Determination of Lisinopril Drug by Oxidative Coupling Reaction with 4-aminonaphthalene-1-sulfonic acid Reagent
2021
[2] Application of second and third generation sequencing in pharmacogenetics
2020
[3] Studies of stress degradation and impurity profiles of some 5-ht3 antagonists
2019
[4] Studies of Stress Degradation of Ramosetron Hydrochloride, a 5-HT3 Antagonist
2018
[5] STRESS DEGRADATION OF LISINOPRIL DIHYDRATE IN DIFFERENT AQUEOUS MEDIA
2018
[6] Studies of Degradation Kinetics of a 5-HT3 Antagonist, Ramosetron Hydrochloride: Effects of Temperature
2018
[7] Simultaneous densitometric analysis of amlodipine, hydrochlorothiazide, lisinopril, and valsartan by HPTLC in pharmaceutical formulations and human plasma
Molecular Crystals and Liquid Crystals, 2017

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.